On June 3, 2025, Immix Biopharma, Inc. entered into an At The Market Offering Agreement to sell shares of its common stock through Citizens JMP Securities, LLC; the company will pay a 3% commission on gross sales.
AI Assistant
IMMIX BIOPHARMA INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.